Professor Matthew Winter

Professor Matt Winter has been a Consultant in Medical Oncology since January 2011 after completing his specialist training in medical oncology in Sheffield, including a Doctor of Medicine clinical and translational research degree in breast cancer. He specialises in and has extensive experience in all aspects of non-surgical systemic breast cancer treatments and has a busy NHS and clinical trial practice. He was also the Lead Breast Cancer clinician at Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust from 2014 - 2023 and is currently the breast cancer sub-speciality lead for the NIHR Yorkshire and Humber Clinical Research Network. In 2022, he became Director of the Sheffield Trophoblastic Disease Centre and since 2018 has also been a member of the Executive Committee of the European Organisation for the Treatment of Trophoblastic Disease (EOTTD), currently as secretary (since 2021) and President-Elect (from May 2025). He has a keen interest in clinical trials and is an author on over 100 published original articles, reviews or conference abstracts in peer reviewed journals in both breast cancer and Gestational Trophoblastic Disease. In 2024, he was appointed as Honorary Professor of Medical Oncology, Division of Clinical Medicine, School of Medicine and Population Health, University of Sheffield. Professor Winter prides himself on establishing excellent rapport with his patients through clear and compassionate communication, and promoting an individualised patient-centred approach.

neoadjuvant, adjuvant and metastatic breast cancer treatment; chemotherapy; endocrine therapy; immunotherapy; targeted therapy; endocrine side effects